Skip to main content
AmigoFish

Retatrutide Before FDA Approval? Lilly Just Changed the Conversation

From On The Pen GLP-1 News · · 20 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.

Back to On The Pen GLP-1 News · Report a problem